Fox, Kim

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

Fox, K. M. (2003) · The Lancet

Acute Myocardial Infarction ResearchBlood Pressure and Hypertension Studies

Cited by 2,142

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet

Heart rate and cardiovascular healthHeart Rate Variability and Autonomic Control

Cited by 1,099

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

Rahimi, K., Bidel, Z., Nazarzadeh, M., Copland, E., Canoy, D., Ramakrishnan, R., Pinho-Gomes, A.-C., Woodward, M., Adler, A., Agodoa, L., et al. (2021) · The Lancet

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 1,074

Resting Heart Rate in Cardiovascular Disease

Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology

Heart rate and cardiovascular healthHeart Rate Variability and Autonomic Control

Cited by 1,062

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., & Ferrari, R. (2008) · The Lancet

Heart rate and cardiovascular healthHeart Rate Variability and Autonomic Control

Cited by 789

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

Dagenais, G. R., Pogue, J., Fox, K., Simoons, M. L., & Yusuf, S. (2006) · The Lancet

Renin-Angiotensin System StudiesBlood Pressure and Hypertension Studies

Cited by 514

Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., & Ferrari, R. (2014) · New England Journal of Medicine

Heart rate and cardiovascular healthHeart Rate Variability and Autonomic Control

Cited by 486

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study

Vidal-Petiot, E., Ford, I., Greenlaw, N., Ferrari, R., Fox, K. M., Tardif, J.-C., Tendera, M., Tavazzi, L., Bhatt, D. L., & Steg, P. G. (2016) · The Lancet

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 470

Ticagrelor in patients with stable coronary disease and diabetes

Steg, P. G., Bhatt, D. L., Simon, T., Fox, K., Mehta, S. R., Harrington, R. A., Held, C., Andersson, M., Himmelmann, A., Ridderstråle, W., et al. (2019) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 365

Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease

Picard, F., Bhatt, D. L., Ducrocq, G., Elbez, Y., Ferrari, R., Ford, I., Tardif, J.-C., Tendera, M., Fox, K. M., & Steg, P. G. (2019) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 39

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities

Mak, K.-H., Vidal-Petiot, E., Young, R., Sorbets, E., Greenlaw, N., Ford, I., Tendera, M., Ferrari, R., Tardif, J.-C., Udell, J. A., et al. (2022) · European Journal of Preventive Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsAcute Myocardial Infarction Research

Cited by 39